These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29871654)
1. B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma. Javier R; Shaikh N; Lesniak MS; Sonabend A; Stupp R; Behdad A; Horbinski C Diagn Pathol; 2018 Jun; 13(1):37. PubMed ID: 29871654 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis. XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976 [TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart. Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022 [TBL] [Abstract][Full Text] [Related]
4. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas. Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345 [TBL] [Abstract][Full Text] [Related]
5. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6. Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541 [TBL] [Abstract][Full Text] [Related]
6. Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: a report of five cases. Imai H; Kajimoto K; Taniwaki M; Miura I; Hatta Y; Hashizume Y; Watanabe M; Shiraishi T; Nakamura S Pathol Int; 2004 Apr; 54(4):231-6. PubMed ID: 15028023 [TBL] [Abstract][Full Text] [Related]
7. Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma. Lim DH; Kim WS; Kim SJ; Yoo HY; Ko YH Anticancer Res; 2015 Jun; 35(6):3333-40. PubMed ID: 26026093 [TBL] [Abstract][Full Text] [Related]
8. [An autopsy case of primary central nervous system lymphoma with diffuse intracerebral lesion]. Kazahaya Y; Doi A; Hamaya K No To Shinkei; 1992 Jan; 44(1):65-70. PubMed ID: 1562388 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma? Qiu T; Chanchotisatien A; Qin Z; Wu J; Chu S World Neurosurg; 2021 Jan; 145():172-177. PubMed ID: 32949800 [TBL] [Abstract][Full Text] [Related]
10. Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy. Ohe Y; Hayashi T; Mishima K; Nishikawa R; Sasaki A; Matsuda H; Uchino A; Tanahashi N Intern Med; 2013; 52(4):483-8. PubMed ID: 23411706 [TBL] [Abstract][Full Text] [Related]
11. Primary cerebral diffuse large B-cell lymphoma relapsed solely in the skin with the same clonal origin. Chuang SS; Liu H; Huang Y; Chio CC; Lin LC Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):77-81. PubMed ID: 19115486 [TBL] [Abstract][Full Text] [Related]
12. Selective central nervous system tropism of primary central nervous system lymphoma. Jiang L; Marlow LA; Cooper SJ; Roemeling CV; Menke DM; Copland JA; Tun HW Int J Clin Exp Pathol; 2010 Oct; 3(8):763-7. PubMed ID: 21151389 [TBL] [Abstract][Full Text] [Related]
13. Primary CNS Lymphoma vs. Tumefactive Multiple Sclerosis: A Diagnostic Challenge. Naeem SB; Niazi F; Baig A; Sadiq H; Sattar M J Coll Physicians Surg Pak; 2018 Jan; 28(1):66-68. PubMed ID: 29290197 [TBL] [Abstract][Full Text] [Related]
14. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice. Deckert M; Montesinos-Rongen M; Brunn A; Siebert R Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin. Lin CH; Kuo KT; Chuang SS; Kuo SH; Chang JH; Chang KC; Hsu HC; Tien HF; Cheng AL Clin Cancer Res; 2006 Feb; 12(4):1152-6. PubMed ID: 16489068 [TBL] [Abstract][Full Text] [Related]
16. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Venetz D; Ponzoni M; Schiraldi M; Ferreri AJ; Bertoni F; Doglioni C; Uguccioni M Int J Cancer; 2010 Nov; 127(10):2300-12. PubMed ID: 20872671 [TBL] [Abstract][Full Text] [Related]
17. A clinicopathological study of primary central nervous system lymphomas & their association with Epstein-Barr virus. Sharma MC; Gupta RK; Kaushal S; Suri V; Sarkar C; Singh M; Kale SS; Sahoo RK; Kumar L; Raina V Indian J Med Res; 2016 May; 143(5):605-15. PubMed ID: 27488004 [TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases. Jamal SE; Li S; Bajaj R; Wang Z; Kenyon L; Glass J; Pang CS; Bhagavathi S; Peiper SC; Gong JZ Brain Tumor Pathol; 2014 Oct; 31(4):265-73. PubMed ID: 24399201 [TBL] [Abstract][Full Text] [Related]
19. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression. Yuan J; Gu K; He J; Sharma S Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492 [TBL] [Abstract][Full Text] [Related]
20. Primary large B-cell lymphoma of the fourth ventricle. Liao CH; Lin SC; Hung SC; Hsu SP; Ho DM; Shih YH J Clin Neurosci; 2014 Jan; 21(1):180-3. PubMed ID: 24012385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]